Outpatient RSV Testing Rates Among US Adults with Lower Respiratory Tract Disease, 2017–2024
Despite increases over time, RSV testing remains infrequent among U.S. adult outpatients. This is particularly true among adults with COPD or CHF exacerbations, where RSV should be part of the differential diagnosis. Infrequent testing may reflect lack of specific RSV treatment options.
Authors
- Jennifer Judy (ORCID: https://orcid.org/0000-0002-2246-9745)
- Negar Aliabadi (ORCID: https://orcid.org/0000-0002-9264-5089)
- Erica Chilson (ORCID: https://orcid.org/0000-0002-4417-3398)
- Katherine K. Perez (ORCID: https://orcid.org/0000-0002-7535-997X)
- Kashmira Date
- Bradford D. Gessner
- Suzanne Landi
- Elizabeth Begier
Institutions
- Pfizer (United States) (US)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1007/s40121-026-01300-z
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00